The abnormal expression of glycolysis-related genes is closely related to the occurrence of various cancers. Multiple glycolysis-related genes are involved in the regulation of glycolysis and affect cancer progression. Currently, research on glycolytic genomes has focused on the establishment of models for the diagnosis, prognosis, and metastasis prediction of various cancer types including breast, ovarian, liver, colorectal, and pancreatic cancers. However, the specific roles of glycolysis-related genes in the occurrence and development of various cancers are still unclear. CD BioGlyco can provide expression profiling of glycolysis-related genes in various cancers based on the high-throughput microarray, sequencing technology, and bioinformatics analysis technology.
Based on the MOPCGM platform, the glycolysis-related genomics research of colorectal cancer is carried out, and a risk model that can be used for the prognosis prediction of patients is constructed.
Our services can support the following applications, including but not limited to:
CD BioGlyco can analyze the expression profile of glycolysis-related genes based on the genomics platform and provides bioinformatics analysis technology to help customers build a glycolysis-related gene feature model that can be diagnosed and predicted. Our experienced teams of scientists, researchers, and technicians provide fast turnaround, high-quality services at competitive prices for worldwide customers. Our customers have direct access to our staff and prompt feedback on their inquiries. If you are interested in our services, please contact us for more details.